TABLE 1.
BCA | BCD | BCF | |
---|---|---|---|
(cm H2O) | (s) | (contractions/min) | |
Transected SC + Intact HGN |
|||
PACAP (10 µg) (n=7) | |||
before | 24.5 ± 7.7 | 50 ± 7 | 1.08 ± 0.24 |
after | 37.7 ± 9.8 | 102 ± 25 | 0.76 ± 0.23* |
PACAP (30 µg) (n=5) | |||
before | 16.7 ± 3.0 | 47 ± 10 | 1.49 ± 0.30 |
after | 49.1 ± 10.6* | 141 ± 56 | 0.38 ± 0.21** |
Transected SC + Sectioned HGN |
|||
PACAP (10 µg) (n=7) | |||
before | 22.4 ± 3.2 | 53 ± 6 | 0.94 ± 0.08 |
after | 36.2 ± 2.7** | 90 ± 19* | 0.59 ± 0.12* |
PACAP (30 µg) (n=4) | |||
before | 22.9 ± 5.2 | 93 ± 37 | 0.71 ± 0.18 |
after | 67.6 ± 15.1* | 276 ± 66 | 0.18 ± 0.04* |
Note. BCA, bladder contraction amplitude; BCD, bladder contraction duration; BCF, bladder contraction frequency; SC, spinal cord; HGN, hypogastric nerves.
P<0.05
P<0.01 (paired t test), compared “after” to “before” the i.t. injection of PACAP.